The number of high-risk factors and the risk of prostate cancer-specific mortality after brachytherapy: implications for treatment selection. [electronic resource]
- International journal of radiation oncology, biology, physics Apr 2012
- e773-9 p. digital
Publication Type: Journal Article
1879-355X
10.1016/j.ijrobp.2011.11.023 doi
Adenocarcinoma--drug therapy Aged Androgen Antagonists--therapeutic use Brachytherapy--methods Cause of Death Combined Modality Therapy--methods Confidence Intervals Follow-Up Studies Humans Male Prostate-Specific Antigen--blood Prostatic Neoplasms--mortality Retrospective Studies Risk Factors